Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial.

Schübel R, Nattenmüller J, Sookthai D, Nonnenmacher T, Graf ME, Riedl L, Schlett CL, von Stackelberg O, Johnson T, Nabers D, Kirsten R, Kratz M, Kauczor HU, Ulrich CM, Kaaks R, Kühn T.

Am J Clin Nutr. 2018 Nov 1;108(5):933-945. doi: 10.1093/ajcn/nqy196.

PMID:
30475957
2.

Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.

Lu DL, Le Cornet C, Sookthai D, Johnson TS, Kaaks R, Fortner RT.

J Natl Cancer Inst. 2018 Jul 16. doi: 10.1093/jnci/djy115. [Epub ahead of print]

PMID:
30016454
3.

Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.

Kühn T, Nonnenmacher T, Sookthai D, Schübel R, Quintana Pacheco DA, von Stackelberg O, Graf ME, Johnson T, Schlett CL, Kirsten R, Ulrich CM, Kaaks R, Kauczor HU, Nattenmüller J.

BMC Gastroenterol. 2018 Jul 13;18(1):113. doi: 10.1186/s12876-018-0840-9.

4.

Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.

Jaskulski S, Jung AY, Behrens S, Johnson T, Kaaks R, Thöne K, Flesch-Janys D, Sookthai D, Chang-Claude J.

Int J Cancer. 2018 Dec 1;143(11):2698-2708. doi: 10.1002/ijc.31647. Epub 2018 Sep 29.

PMID:
29974464
5.

Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.

Graf ME, Sookthai D, Johnson T, Schübel R, Maldonado SG, Pletsch-Borba L, Katzke V, Bugert P, Hoffmeister M, Kaaks R, Kühn T.

Int J Cancer. 2018 Dec 1;143(11):2659-2667. doi: 10.1002/ijc.31623. Epub 2018 Oct 9.

PMID:
29923180
6.

Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.

Nattenmüller CJ, Kriegsmann M, Sookthai D, Fortner RT, Steffen A, Walter B, Johnson T, Kneisel J, Katzke V, Bergmann M, Sinn HP, Schirmacher P, Herpel E, Boeing H, Kaaks R, Kühn T.

BMC Cancer. 2018 May 31;18(1):616. doi: 10.1186/s12885-018-4548-6.

7.

Iron status in relation to cancer risk and mortality: Findings from a population-based prospective study.

Quintana Pacheco DA, Sookthai D, Graf ME, Schübel R, Johnson T, Katzke VA, Kaaks R, Kühn T.

Int J Cancer. 2018 Aug 1;143(3):561-569. doi: 10.1002/ijc.31384. Epub 2018 Apr 1.

PMID:
29574909
8.

Red meat consumption and risk of cardiovascular diseases-is increased iron load a possible link?

Quintana Pacheco DA, Sookthai D, Wittenbecher C, Graf ME, Schübel R, Johnson T, Katzke V, Jakszyn P, Kaaks R, Kühn T.

Am J Clin Nutr. 2018 Jan 1;107(1):113-119. doi: 10.1093/ajcn/nqx014.

PMID:
29381787
9.

Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.

Katzke VA, Sookthai D, Johnson T, Kühn T, Kaaks R.

BMC Med. 2017 Dec 19;15(1):218. doi: 10.1186/s12916-017-0976-4.

10.

Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.

Floegel A, Kühn T, Sookthai D, Johnson T, Prehn C, Rolle-Kampczyk U, Otto W, Weikert C, Illig T, von Bergen M, Adamski J, Boeing H, Kaaks R, Pischon T.

Eur J Epidemiol. 2018 Jan;33(1):55-66. doi: 10.1007/s10654-017-0333-0. Epub 2017 Nov 27.

11.

Reproducibility of serum oxysterols and lanosterol among postmenopausal women: Results from EPIC-Heidelberg.

Lu DL, Sookthai D, Le Cornet C, Katzke VA, Johnson TS, Kaaks R, Fortner RT.

Clin Biochem. 2018 Feb;52:117-122. doi: 10.1016/j.clinbiochem.2017.11.001. Epub 2017 Nov 22.

PMID:
29108727
12.

Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.

Kühn T, Sookthai D, Graf ME, Schübel R, Freisling H, Johnson T, Katzke V, Kaaks R.

Br J Cancer. 2017 Nov 7;117(10):1572-1579. doi: 10.1038/bjc.2017.313. Epub 2017 Sep 12.

13.

Biological reproducibility of circulating P-Selectin, Thrombopoietin, GPIIb/IIIa and Thrombomodulin over one year.

Graf ME, Sookthai D, Johnson T, Schübel R, Katzke V, Bugert P, Hoffmeister M, Kaaks R, Kühn T.

Clin Biochem. 2017 Nov;50(16-17):942-946. doi: 10.1016/j.clinbiochem.2017.05.017. Epub 2017 May 29.

PMID:
28571971
14.

The effects of intermittent calorie restriction on metabolic health: Rationale and study design of the HELENA Trial.

Schübel R, Graf ME, Nattenmüller J, Nabers D, Sookthai D, Gruner LF, Johnson T, Schlett CL, von Stackelberg O, Kirsten R, Habermann N, Kratz M, Kauczor HU, Ulrich CM, Kaaks R, Kühn T.

Contemp Clin Trials. 2016 Nov;51:28-33. doi: 10.1016/j.cct.2016.09.004. Epub 2016 Sep 28.

PMID:
27687742
15.

Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.

Dietrich S, Floegel A, Troll M, Kühn T, Rathmann W, Peters A, Sookthai D, von Bergen M, Kaaks R, Adamski J, Prehn C, Boeing H, Schulze MB, Illig T, Pischon T, Knüppel S, Wang-Sattler R, Drogan D.

Int J Epidemiol. 2016 Oct;45(5):1406-1420. Epub 2016 Sep 1.

PMID:
27591264
16.

Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year.

Kühn T, Rohrmann S, Sookthai D, Johnson T, Katzke V, Kaaks R, von Eckardstein A, Müller D.

Clin Chem Lab Med. 2017 Feb 1;55(2):261-268. doi: 10.1515/cclm-2016-0374.

17.

Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study.

Kühn T, Floegel A, Sookthai D, Johnson T, Rolle-Kampczyk U, Otto W, von Bergen M, Boeing H, Kaaks R.

BMC Med. 2016 Jan 28;14:13. doi: 10.1186/s12916-016-0552-3.

18.

Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.

Li K, Hüsing A, Sookthai D, Bergmann M, Boeing H, Becker N, Kaaks R.

Cancer Prev Res (Phila). 2015 Sep;8(9):777-85. doi: 10.1158/1940-6207.CAPR-14-0424. Epub 2015 Jun 15.

19.

Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.

Tikk K, Sookthai D, Fortner RT, Johnson T, Rinaldi S, Romieu I, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Mattiello A, Agudo A, Menéndez V, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, Monninkhof EM, Onland-Moret NC, Andresson A, Sund M, Weiderpass E, Khaw KT, Key TJ, Travis RC, Merritt MA, Riboli E, Dossus L, Kaaks R.

Breast Cancer Res. 2015 Mar 31;17:49. doi: 10.1186/s13058-015-0563-6.

20.

Lag times between lymphoproliferative disorder and clinical diagnosis of chronic lymphocytic leukemia: a prospective analysis using plasma soluble CD23.

Kaaks R, Sookthai D, Łuczyńska A, Oakes CC, Becker S, Johnson T, Johansson A, Melin B, Sjöberg K, Trichopoulos D, Trichopoulou A, Lagiou P, Mattiello A, Tumino R, Masala G, Agnoli C, Boeing H, Aleksandrova K, Brennan P, Franceschi S, Roulland S, Casabonne D, de Sanjose S, Sánchez MJ, Huerta JM, Ardanaz E, Sala N, Overvad K, Tjønneland A, Halkjær J, Weiderpass E, Bueno-de-Mesquita HB, Vermeulen R, Peeters PH, Vineis P, Kelly RS, Khaw KT, Travis RC, Key TJ, Riboli E, Nieters A.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):538-45. doi: 10.1158/1055-9965.EPI-14-1107. Epub 2014 Dec 26.

21.

Prolactin determinants in healthy women: A large cross-sectional study within the EPIC cohort.

Tikk K, Sookthai D, Johnson T, Dossus L, Clavel-Chapelon F, Tjønneland A, Olsen A, Overvad K, Baglietto L, Rinaldi S, Romieu I, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Agnoli C, Tumino R, Sacerdote C, Mattiello A, Buckland G, Sánchez S, Molina-Montes E, Amiano P, Castaño JM, Barricarte A, Bueno-de-Mesquita HB, Monninkhof EM, Onland-Moret NC, Idahl A, Lundin E, Weiderpass E, Lund E, Waaseth M, Khaw KT, Key TJ, Travis RC, Gunter MJ, Riboli E, Kaaks R.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2532-42. doi: 10.1158/1055-9965.EPI-14-0613. Epub 2014 Aug 20.

22.

Primary preventive potential for stroke by avoidance of major lifestyle risk factors: the European Prospective Investigation into Cancer and Nutrition-Heidelberg cohort.

Tikk K, Sookthai D, Monni S, Gross ML, Lichy C, Kloss M, Kaaks R.

Stroke. 2014 Jul;45(7):2041-6. doi: 10.1161/STROKEAHA.114.005025. Epub 2014 May 29.

PMID:
24876086
23.

Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.

Tikk K, Sookthai D, Johnson T, Rinaldi S, Romieu I, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Pala V, Tumino R, Rosso S, Panico S, Agudo A, Menéndez V, Sánchez MJ, Amiano P, Huerta Castaño JM, Ardanaz E, Bueno-de-Mesquita HB, Monninkhof E, Onland-Moret C, Andersson A, Sund M, Weiderpass E, Khaw KT, Key TJ, Travis RC, Gunter MJ, Riboli E, Dossus L, Kaaks R.

Ann Oncol. 2014 Jul;25(7):1422-8. doi: 10.1093/annonc/mdu150. Epub 2014 Apr 8.

PMID:
24718887
24.

Risk factors for cancers of unknown primary site: Results from the prospective EPIC cohort.

Kaaks R, Sookthai D, Hemminki K, Krämer A, Boeing H, Wirfält E, Weiderpass E, Overvad K, Tjønneland A, Olsen A, Peeters PH, Bueno-de-Mesquita HB, Panico S, Pala V, Vineis P, Quirós JR, Ardanaz E, Sánchez MJ, Chirlaque MD, Larrañaga N, Brennan P, Trichopoulos D, Trichopoulou A, Lagiou P, Hallmans G, Khaw KT, Key TJ, Riboli E, Canzian F.

Int J Cancer. 2014 Nov 15;135(10):2475-81. doi: 10.1002/ijc.28874. Epub 2014 Apr 10.

25.

Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.

Kaaks R, Johnson T, Tikk K, Sookthai D, Tjønneland A, Roswall N, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Rinaldi S, Romieu I, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S, Tumino R, Sacerdote C, Panico S, Buckland G, Argüelles M, Sánchez MJ, Amiano P, Chirlaque MD, Ardanaz E, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Gram IT, Lund E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A.

Int J Cancer. 2014 Jun 1;134(11):2683-90. doi: 10.1002/ijc.28589. Epub 2013 Nov 19.

26.

Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.

Kaaks R, Tikk K, Sookthai D, Schock H, Johnson T, Tjønneland A, Olsen A, Overvad K, Clavel-Chapelon F, Dossus L, Baglietto L, Rinaldi S, Chajes V, Romieu I, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Ricceri F, Mattiello A, Buckland G, Ramón Quirós J, Sánchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bas Bueno-de-Mesquita H, van Gils CH, Peeters PH, Andersson A, Sund M, Weiderpass E, Khaw KT, Wareham N, Key TJ, Travis RC, Merritt MA, Gunter MJ, Riboli E, Lukanova A.

Int J Cancer. 2014 Apr 15;134(8):1947-57. doi: 10.1002/ijc.28528. Epub 2013 Oct 24.

Supplemental Content

Loading ...
Support Center